Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Dense AB1-007 (Abraxane) in Adjuvant Chemotherapy for Breast Cancer: A Feasibility Study

NCT00308178 is registered in ClinicalTrials.gov with Harold J. Burstein, MD, PhD as lead sponsor.

NCT NCT00308178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00308178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Dense AB1-007 (Abraxane) in Adjuvant Chemotherapy for Breast Cancer: A Feasibility Study
Lead sponsor
Harold J. Burstein, MD, PhD
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2006
Completion date
June 30, 2008
Enrollment
66 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer